Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)

ClinicalTrials.gov ID: NCT02664558

Public ClinicalTrials.gov record NCT02664558. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 28, 2026, 10:57 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Double-BLInd, Placebo- Controlled Study of UBEnimex in Patients With Pulmonary ARTerial HYpertension (WHO Group 1) (LIBERTY)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This proof-of-concept study is designed as a Phase 2, multicenter, randomized, double-blind, placebo controlled study comparing ubenimex with placebo in patients with pulmonary arterial hypertension (PAH) (World Health Organization \[WHO\] Group 1) and have a WHO/New York Heart Association (NYHA) Functional Classification (WHO/NYHA-FC) of II or III.

Study identification

NCT ID
NCT02664558
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Eiger BioPharmaceuticals
Industry
Enrollment
61 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2016 (Type not available)
Primary completion
Nov 2017 (Actual)
Completion
Jan 2018 (Actual)
Last update posted
Mar 6, 2023

2016 – 2018

United States locations

U.S. sites
28
U.S. states
18
U.S. cities
25
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35233 —
California Heart Center Foundation, An Affiliate of Cedars-Sinai Heart Institute, Cedars-Sinai Medical Care Foundation Beverly Hills California 90211 —
UCSD Medical Center La Jolla California 92103 —
Stanford University Medical Center Stanford California 94305 —
University of Colorado Denver Aurora Colorado 80045 —
University of Florida Gainesville Florida 32610 —
Cleveland Clinic, Florida Weston Florida 33331 —
Kentuckiana Pulmonary Associates Louisville Kentucky 40202 —
Chest Medicine Associates South Portland Maine 04106 —
Johns Hopkins University, Pulmonary and Critical Care Medicine Baltimore Maryland 21205 —
Tufts Medical Center Boston Massachusetts 02111 —
Brigham and Women's Hospital Boston Massachusetts 02115 —
Boston University School of Medicine Boston Massachusetts 02118 —
University of Michigan Ann Arbor Michigan 48109 —
Mayo Clinic College of Medicine Rochester Minnesota 55905 —
Washington University St Louis Missouri 63130 —
Weill Cornell Medicine New York New York 10065 —
The University of North Carolina at Chapel Hill Chapel Hill North Carolina 27599 —
Duke University Medical Center Durham North Carolina 27710 —
Cleveland Clinic Respiratory Institute Cleveland Ohio 44195 —
University of Pennsylvania Philadelphia Pennsylvania 19104 —
Allegheny General Hospital Pittsburgh Pennsylvania 15212 —
University of Pennsylvania Medical Center Pittsburgh Pennsylvania 15213 —
Alpert Medical School of Brown University Rhode Island Hospital Providence Rhode Island 02903 —
Vanderbilt University Medical Center Nashville Tennessee 37232 —
UT Southwestern Medical Center Dallas Texas 75390 —
Houston Methodist Hospital Houston Texas 77030 —
University Texas Health Science Center San Antonio Texas 78229 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02664558, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 6, 2023 · Synced Oct 28, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02664558 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →